Multimodal Imaging and Biomarkers in Cardiac Amyloidosis
Amyloidosis is a progressive infiltrative disease instigated by the extracellular deposition of amyloid fibrils in various organs such as the heart, kidney, and peripheral nerves. Cardiac amyloid deposits cause restrictive cardiomyopathy, leading to a poor prognosis in systemic amyloidosis. The most...
Main Authors: | Mi-Hyang Jung, Suyon Chang, Eun Ji Han, Jong-Chan Youn |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/12/3/627 |
Similar Items
-
Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis
by: Alberto Aimo, MD, et al.
Published: (2020-07-01) -
Utility and pitfalls of the electrocardiogram in the evaluation of cardiac amyloidosis
by: Perryn Lin Fei Ng, et al.
Published: (2022-07-01) -
Impact of tricuspid regurgitation on survival in patients with cardiac amyloidosis
by: Jerome Fagot, et al.
Published: (2021-02-01) -
The short and long‐term characteristics and outcomes of patients with grade 1 myocardial uptake on cardiac scintigraphy
by: Osnat Itzhaki Ben Zadok, et al.
Published: (2023-06-01) -
Editorial: Proceedings and predictions in cardiac amyloidosis: unsolved mysteries and challenges for the future
by: Aldostefano Porcari, et al.
Published: (2023-07-01)